Nath Bio-Genes (India) Ltd

NSE: NATHBIOGEN · BSE: 537291 · Food, Beverages & Tobacco · 17 announcements

Share price: ₹136.10
Market cap: ₹258.6 Cr
Revenue (annual): ₹445.1 Cr
Net profit (annual): ₹41.63 Cr
P/E (TTM): 7.1×Sector 28.6×
Promoter holding: 45.60%+0.00% QoQ
FII holding: 0.26%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 4 Other Announcement 3 Financial Results 3 Board Meeting Outcome 3 Annual General Meeting 2 ED Probe / Tax Survey 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

29 Jul 2026 16:16 IST BSE

Financial Results

Nath Bio-Genes (India) Q1 FY27 Results: Net Profit ₹32.3 Cr, Up 14.1% YoY

Nath Bio-Genes (India) Ltd reported revenue from operations of ₹328.4 Cr (+15.8% YoY) and net profit of ₹32.3 Cr (+14.1% YoY) for Q1 FY27.

Key figure: Net profit ₹32.3 Cr · +14.1% YoY

Open full results → Read the filing ↗

4 May 2026 17:08 IST BSE

Financial Results

Nath Bio-Genes (India) Q4 FY26 Results: Net Profit ₹0 Cr

Nath Bio-Genes (India) Ltd reported revenue from operations of ₹51.6 Cr (-0.6% YoY) and net profit of ₹0 Cr for Q4 FY26.

Key figure: Net profit ₹0 Cr

Open full results → Read the filing ↗

4 May 2026 17:07 IST BSE

Financial Results

Nath Bio-Genes (India) Financial Results

Nath Bio-Genes (India) Ltd reported consolidated annual revenue of ₹445.10 Crore for FY26. The Board recommended a dividend of ₹2 per share (20%) and approved the reappointment of Mr. Hitesh Rajnikant Purohit as an Independent Director for a second five-year term starting March 2027.

Value: ₹445.1 Cr

Read the filing ↗